G. Lombardozzi

Vortioxetine vs. Other Antidepressants in Patients with Major Depressive Episode With or Without Substance Use Disorder

G. Kotzalidis, S. de Filippis, I. Cuomo, 2021, Current neuropharmacology.

P.0669 Differential response to three antidepressants in patients with major depressive episode who suffered Covid-19–related trauma

G. Trovini, E. Amici, F. Perrini, 2021, European Neuropsychopharmacology.

Treatment-resistant schizophrenia: Addressing white matter integrity, intracortical glutamate levels, clinical and cognitive profiles between early- and adult-onset patients

A. Bozzao, G. Kotzalidis, F. Iasevoli, 2021, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Motivation as a Measurable Outcome in Stroke Rehabilitation: A Systematic Review of the Literature

M. Iosa, D. De Bartolo, Giulio Verrienti, 2023, International journal of environmental research and public health.

Developmental trajectories in psychiatric disorders: does substance/alcohol use moderate the effects of affective temperaments as moderators of age at onset? A study in post-acute, hospitalized patients with psychotic or DSM-5 bipolar or major depressive disorders

G. Battagliese, G. Kotzalidis, A. de Bartolomeis, 2021, Journal of addictive diseases.

The burden of depressive disorders in musculoskeletal diseases: is there an association between mood and inflammation?

C. Niolu, A. Siracusano, M. Chimenti, 2021, Annals of General Psychiatry.

Differential response to three antidepressants in patients with major depressive episode who suffered Covid-19-related trauma.

G. Kotzalidis, G. Trovini, E. Amici, 2022, Current neuropharmacology.